Filing metadata

Accession number
0000950170-23-030213
Form type
Form 4
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Jun 27, 2023
Reporting period
Jun 23, 2023
Description
Insider transaction

Explore SEC Filings Hub